Ligand-independent activation of the estrogen receptors alpha and beta by mutations of a conserved tyrosine can be abolished by antiestrogens.

Abstract excerpt

It has recently been suggested that mutation of a conserved tyrosine to asparagine within the ligand-binding domain of the estrogen receptor (ER) alpha confers hormone-independent activation and insensitivity to antiestrogens (Q. X. Zhang et al., Cancer Res., 57: 1244-1249, 1997). In view of the recent discovery of ERbeta and the development of the novel nonsteroidal antiestrogen EM-800 and its active metabolite...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to COS Cells
• Share to Estrogen Antagonists
• Share to Ligands